BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  MorphoSys to Host Q3 2017 Conference Call on November 7, 2017

  MorphoSys AG will publish its first nine months’ 2017 results on November 7, 2017 at 7:00 am CET.

  October 26, 2017

   · 

  1 min read
• Genetown

  VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares

  VBI also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of common shares offered in the public offering.

  October 26, 2017

   · 

  5 min read
• Business

  Vital Therapies Announces Third Quarter 2017 Financial Results

  Vital Therapies announced results for the third quarter ended September 30, 2017.

  October 26, 2017

   · 

  8 min read
• Business

  Merit Medical Reports Results for Third Quarter 2017

  Merit Medical Systems today announced revenue of $179.3M for the quarter ended September 30, 2017.

  October 26, 2017

   · 

  22 min read
• BioCapital

  Compugen to Present at the Annual Meeting of the Society for Immunotherapy of Cancer Next Month

  Compugen announced it will present two posters with new data on COM701, the Company’s first-in class immuno-oncology therapeutic antibody candidate targeting PVRIG, and COM902.

  October 26, 2017

   · 

  3 min read
• Business

  Sarepta Therapeutics Announces Third Quarter 2017 Financial Results and Recent Corporate Developments

  The company reported financial results for the third quarter of 2017.

  October 26, 2017

   · 

  18 min read
• Business

  PRA Health Sciences, Inc. Reports Third Quarter 2017 Results and Updates Full Year 2017 Guidance

  For the three months ended September 30, 2017, service revenue was $494.6 million, which represents growth of 23.7%, or $94.7 million.

  October 26, 2017

   · 

  28 min read
• Pharm Country

  Misonix Cites Significant Healthcare Cost Savings Using BoneScalpel in Bone Removal Procedures

  Misonix cited data that demonstrated the use of BoneScalpel can produce up to a 40% cost reduction in biologic grafting material spend in spinal fusion procedures.

  October 26, 2017

   · 

  4 min read
• Business

  Alimera Sciences to Report Third Quarter 2017 Results November 1st, 2017

  An accompanying conference call will be hosted by Dan Myers, Chief Executive Officer and Rick Eiswirth, President and Chief Financial Officer to discuss the results.

  October 26, 2017

   · 

  1 min read
• Biotech Bay

  Amaranth Medical Showcases Breadth of BRS Pipeline at TCT, Unveiling 9-mo Interim Imaging Results from 98 micron MAGNITUDE and Update on 115-micron APTITUDE

  New data to be presented at the meeting include nine-month imaging results from 12 of the 70 patients enrolled in the RENASCENT-III study of MAGNITUDE.

  October 26, 2017

   · 

  4 min read